Our laboratory is accredited according to ISO17025 for virucidal tests. Accreditation n°1-7113. Scope available on www.cofrac.fr
Our news
🆕
We are pleased to announce that as part of their strategic partnership, #VirHealth and #NeoVirTech offer a wide range of tests to evaluate the efficiency of disinfectants and disinfection equipment on MPOX mimetic viral strains:
product efficiency screening with the VACV ANCHOR system, standardized tests according to EN/ASTM/ISO standards, coating/materials/textiles tests and R&D studies according to client’s specifications.
Transformation of SMEs through Innovation
🏆We are pleased to announce that our company has been selected as the winner of the France 2030 regionalized call for projects in Auvergne-Rhône-Alpes region, focusing on "Transformation of SMEs through Innovation". It relates to our project on the Performance and Durability of Antimicrobial Products. MORE
Evaluating the efficacy of surface disinfectants
VirHealth is pleased to announce the implementation of new trial procedures aimed at evaluating the efficacy of surface disinfectants, whether used with or without mechanical action (wipes), as well as surface disinfection systems through airborne methods, against Adeno-Associated-Virus (AAV) vectors used in gene therapy. MORE
Surface disinfection - New Test Bench
VirHealth has developed a new test bench to meet the requirements of EN17272 (2020, airborne disinfection system) for small-enclosure efficacy tests of 2 m3. MORE
SURFACES AND MATERIALS ANTIVIRAL ACTIVITY
We are pleased to announce the publication of the study "Antiviral Activity of Active Materials: Standard and Finger-Pad-Based Innovative Experimental Approaches" in the international review Materials. MORE
Partnership with NeoVirTech
NeoVirTech and VirHealth join their virology expertise to provide customers one of the most extended virus disinfection measurement and R&D platform in France and in Europe. MORE
SURFACES AND MATERIALS ANTIVIRAL ACTIVITY
Surfaces with antiviral activities participate in the management of viral contamination by reducing the infectious virus load over time. We offer standardized or adapted protocols to evaluate the antiviral efficacy of porous and non-porous surfaces on a large panel of viruses (enveloped and non- enveloped) including alpha/beta coronaviruses. MORE